Eltrombopag in Preparation for Surgery in Patients With Severe Myh9 ‐Related Thrombocytopenia

American Journal of Hematology- United States

doi 10.1002/ajh.25500

Full Text

Abstract

Available in

Categories

Hematology

Date

Authors

Publisher

Wiley

Related search

Massive Mediastinal Enlargement Due to Extramedullary Haematopoiesis in a Patient With MYH9 -Related Thrombocytopenia

British Journal of Haematology
Hematology
2017English

Therapy Induced Iron Deficiency in Children Treated With Eltrombopag for Immune Thrombocytopenia

American Journal of Hematology
Hematology
2017English

Eltrombopag-Based Combination Treatment for Immune Thrombocytopenia

Therapeutic Advances in Hematology
Hematology
2018English

A Phase II Trial of Eltrombopag for Patients With Chronic Lymphocytic Leukaemia (CLL) and Thrombocytopenia

British Journal of Haematology
Hematology
2018English

Thrombocytopenia in Patients With Severe Acute Respiratory Syndrome (Review)

Hematology
Hematology
2005English

Tolerability and Efficacy of Eltrombopag in Chronic Immune Thrombocytopenia

Clinical and Applied Thrombosis/Hemostasis
MedicineHematology
2016English

Bleeding-Related Episodes (BRE) in Patients With Immune Thrombocytopenia (ITP) Receiving Eltrombopag (EPAG) or Romiplostim (ROMI): Real World Evidence From 26 US Institutions

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Recurrent Coronary Thrombus in a Patient With Chronic Immune Thrombocytopenia With Treatment Using Eltrombopag

Case Reports in Cardiology
Cardiovascular MedicineCardiology
2019English

Thrombopoietin Level Predicts Response to Treatment With Eltrombopag and Romiplostim in Immune Thrombocytopenia

American Journal of Hematology
Hematology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy